RD204C
Phase 3
Completed
- Conditions
- Knee osteoarthritis
- Registration Number
- JPRN-jRCT2080223476
- Lead Sponsor
- CHUGAI PHARMACEUTICAL CO., LTD.
- Brief Summary
The efficacy and safety of consecutive 5 weekly intra-knee articular injections of NRD101 were comparable with comparator. It was confirmed that NRD101 was well tolerated in Chinese Knee OA patient.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 267
Inclusion Criteria
(1) Patients diagnosed with knee osteoarthritis based on the American College of Rheumatology (ACR) Clinical Classification Criteria.
(2) The study knee is classified as Kellgren-Lawrence Grade 2 or Grade 3.
Exclusion Criteria
(1) Patients diagnosed with secondary knee osteoarthritis.
(2) Patients with other diseases/disorders causing functional impairment of the knee.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method